CHRIS AMOS to Inflammation
This is a "connection" page, showing publications CHRIS AMOS has written about Inflammation.
Connection Strength
0.530
-
Multistage analysis of variants in the inflammation pathway and lung cancer risk in smokers. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1213-21.
Score: 0.218
-
Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma Progression. J Invest Dermatol. 2019 11; 139(11):2352-2358.e3.
Score: 0.089
-
Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer. J Natl Cancer Inst. 2015 Nov; 107(11).
Score: 0.069
-
Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke. Cancer Discov. 2011 Oct; 1(5):420-9.
Score: 0.052
-
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis. EBioMedicine. 2024 Feb; 100:104991.
Score: 0.031
-
Inflammatory Biomarkers Differ among Hospitalized Veterans Infected with Alpha, Delta, and Omicron SARS-CoV-2 Variants. Int J Environ Res Public Health. 2023 02 08; 20(4).
Score: 0.029
-
Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer. Genet Epidemiol. 2021 02; 45(1):99-114.
Score: 0.024
-
Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls. Hum Genet. 2013 05; 132(5):579-89.
Score: 0.014
-
Inheritance of susceptibility to bleomycin-induced pulmonary fibrosis in the mouse. Cancer Res. 1996 Jun 01; 56(11):2596-601.
Score: 0.005